Abstract-cAMP/protein kinase (PK)A activation represents a key signaling mechanism for neurohormonal stimulation of diversified physiological processes. Using real-time, fluorescence resonance energy transfer-based imaging of PKA activity in neonatal cardiac myocytes, we report that sustained activation of PKA induced by ␤-adrenoceptor (␤AR) dictates signaling propagation for substrate phosphorylation and myocyte contraction. Activation of ␤ARs in wild-type myocytes induces strong and sustained PKA activities, which are rapidly attenuated on washing away agonist or adding antagonist to the cells. The sustained PKA activities promote signaling propagation to the sarcoplasmic reticulum for phosphorylation of phospholamban and increases in myocyte contraction. Key Words: protein kinase A phosphorylation Ⅲ adrenergic receptor Ⅲ phospholamban Ⅲ contraction C AMP/protein kinase (PK)A activation represents a key signaling mechanism for neurohormonal stimulation controlling diversified physiological processes from cardiac contraction and energy metabolism to behaviors. Activation of adrenergic receptors is the major neurohormonal mechanism controlling cAMP/PKA activities for cardiac performance during stresses. ␤-Adrenoceptors (␤ARs) conduct stimulatory effects by elevation intracellular cAMP levels and subsequent activation of cAMP-dependent PKA. On activation, PKA exerts 2 major functions in cardiac myocytes: enhancement of cardiac contraction through phosphorylation of plasmalemma and sarcomeric ion channels and myofibril contractile proteins, 1 and desensitization of ligand-bound ␤ARs through phosphorylation of activated receptors. 2 Given multiple PKA targets within distinct subcellular regions, a spatially confined PKA activity is essential to warrant response specificity. Indeed, signaling proteins including receptors, G proteins, and adenylyl cyclases, are compartmentalized within specific intracellular regions for appropriate functioning of cAMP/PKA signaling pathway. 3 Additionally, PKA is anchored via a kinase anchoring protein close to its specific targets. 4 This organization confines cAMP to discrete intracellular regions, leading to activation of selected pools of PKA on stimulation. 5 The machinery that underpins compartmentalized cAMP signaling has been extensively studied and is only now becoming fully appreciated. 6 Fundamental to shape cAMP gradients is activity of the phosphodiesterases (PDEs), a superfamily of enzymes that hydrolyze cAMP. PDEs associate with distinct signaling complexes or subcellular structures to provide functional proximity to cAMP. It is well documented that cAMP gradients are regulated by different PDEs in magnitude, kinetics, and localization, which are proposed to transiently induce local PKA activities for a set of specific substrates. 6 -8 PDE3 and PDE4 families account for more than 90% of activities for cAMP hydrolysis in hearts. 9 PDE4 enzymes are enriched in both M and Z lines in the proximity of ␤ARs. 10 Inhibition of PDE4 or deletion of PDE4D results in higher cellular cAMP levels and enhances myocyte contraction responses on ␤AR stimulation. 10 Although PKA is responsible for the majority of effects from increased cellular cAMP levels under ␤AR stimulation, little progress has been made to understand how elevated levels of cellular cAMP are translated into activation of PKA anchored in Original
C AMP/protein kinase (PK)A activation represents a key signaling mechanism for neurohormonal stimulation controlling diversified physiological processes from cardiac contraction and energy metabolism to behaviors. Activation of adrenergic receptors is the major neurohormonal mechanism controlling cAMP/PKA activities for cardiac performance during stresses. ␤-Adrenoceptors (␤ARs) conduct stimulatory effects by elevation intracellular cAMP levels and subsequent activation of cAMP-dependent PKA. On activation, PKA exerts 2 major functions in cardiac myocytes: enhancement of cardiac contraction through phosphorylation of plasmalemma and sarcomeric ion channels and myofibril contractile proteins, 1 and desensitization of ligand-bound ␤ARs through phosphorylation of activated receptors. 2 Given multiple PKA targets within distinct subcellular regions, a spatially confined PKA activity is essential to warrant response specificity. Indeed, signaling proteins including receptors, G proteins, and adenylyl cyclases, are compartmentalized within specific intracellular regions for appropriate functioning of cAMP/PKA signaling pathway. 3 Additionally, PKA is anchored via a kinase anchoring protein close to its specific targets. 4 This organization confines cAMP to discrete intracellular regions, leading to activation of selected pools of PKA on stimulation. 5 The machinery that underpins compartmentalized cAMP signaling has been extensively studied and is only now becoming fully appreciated. 6 Fundamental to shape cAMP gradients is activity of the phosphodiesterases (PDEs), a superfamily of enzymes that hydrolyze cAMP. PDEs associate with distinct signaling complexes or subcellular structures to provide functional proximity to cAMP. It is well documented that cAMP gradients are regulated by different PDEs in magnitude, kinetics, and localization, which are proposed to transiently induce local PKA activities for a set of specific substrates. 6 -8 PDE3 and PDE4 families account for more than 90% of activities for cAMP hydrolysis in hearts. 9 PDE4 enzymes are enriched in both M and Z lines in the proximity of ␤ARs. 10 Inhibition of PDE4 or deletion of PDE4D results in higher cellular cAMP levels and enhances myocyte contraction responses on ␤AR stimulation. 10 Although PKA is responsible for the majority of effects from increased cellular cAMP levels under ␤AR stimulation, little progress has been made to understand how elevated levels of cellular cAMP are translated into activation of PKA anchored in discrete cellular domains, and less is known regarding how PKA conducts signal propagation for subsequent phosphorylation of substrates in cellular responses. In particular, activation of ␤ 2 ARs leads to significant increases of cellular cAMP levels, which can be further enhanced when function of PDE4 is disrupted by genetic deletion or pharmacological inhibition. 11 However, the increased cAMP levels induced by ␤ 2 AR activation fails to promote significant increases in PKA phosphorylation of phospholamban and PKA-dependent contraction responses in rat cardiac myocytes. 12 In animal hearts, deletion of ␤ 2 AR genes does not affect myocardium contraction under exercise or perfusion with ␤AR agonist isoproterenol 13 ; however, stimulation of overexpressed human ␤ 2 ARs significantly enhances cardiac performance. 14 These data suggest that activation of PKA is highly restricted, and is dependent on the stimulation, time, and location.
Here, we tested a hypothesis that in cardiac myocytes, ␤AR-induced PKA activities are restricted within local vicinities and can differentially phosphorylate activated receptors and/or substrates based on locations. By using real-time, fluorescence resonance energy transfer (FRET)-based imaging of PKA activities in living cells, we report, for the first time, that sustainability of PKA activation induced by ␤AR subtypes dictates signaling propagation in cardiac myocytes for substrate phosphorylation and contraction responses.
Materials and Methods
All protocols are approved by the Institutional Policies of DAR at the University of Illinois at Urbana. Neonatal and adult myocytes were isolated from mice as previously described. 15 Myocytes were infected with viruses to express A-kinase activity reporter (AKAR2.2) to probe PKA activities with methods as previously described. 16 In addition, myocyte contraction assay were carried out accordingly in both neonatal and adult cells. 15 For Western blot, myocytes were stimulated with isoproterenol in the presence or absence of pretreatment of PDE4 and Gi inhibitors. The cell lysates were subjected to western blot with antibodies accordingly.
Statistical Analysis
One or 2-way ANOVA and Student's t test were performed as appropriate using Prism software.
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournals.org.
Results

Stimulation of ␤ARs Induces Sustained Increases in PKA Activities in Cardiac Myocytes
We have recently successfully analyzed PKA-mediated phosphorylation with AKAR2.2 in living cells. 16 Recombinant adenovirus delivery of the PKA biosensor in neonatal mouse cardiac myocytes yielded more than 70% positive cells, a much more efficient method than plasmid transfection ( Figure I in the online data supplement). Stimulation of ␤ARs with isoproterenol induced a rapid and sustained increase in FRET ratio in wild-type myocytes (t 1/2 ϭ7.68Ϯ2.28 seconds and initial increase, 0.27Ϯ0.02; nϭ22; Figure 1A and supplemental Figure I ) but not in myocytes isolated from mice lacking both ␤ 1 and ␤ 2 AR genes, in which the increase was recuperated by direct stimulation of adenylyl cyclases with forskolin ( Figure 1B ; nϭ15). The increase was sustained at high levels ( Figure 1A ). Similar responses were observed in myocytes with plasmid transfection (t 1/2 ϭ7.80Ϯ1.74 seconds and initial increase, 0.26Ϯ0.03; nϭ5; supplemental Figure I ). The agonist-induced increases in FRET ratio were rapidly reversed by addition of ␤AR-specific antagonist alprenolol ( Figure 1C ) or by washing away isoproterenol ( Figure 1D ), indicating agonist occupancy is necessary to maintain elevated PKA activities. In contrast, addition of alprenolol did not block future increase in FRET ratio induced by forskolin ( Figure 1C ). The increases in FRET ratio induced by both isoproterenol and forskolin were rapidly attenuated by addition of a PKA-specific inhibitor H-89 that also blocked future stimulation by forskolin ( Figure 1E ). In addition, a cAMP analog 8-br-cAMP induced rapid increases in FRET ratio, which were also attenuated by addition of H-89 (Figure 1F). Together, our data suggest that the AKAR reporter expressed in mouse neonatal cardiac myocytes is fully responsive to diversified stimuli and displays dynamic changes in FRET ratio.
Recent progress has significantly improved our understanding of how cellular cAMP induced by adrenergic stimulation is confined within subcellular domains by PDE activities. We sought to examine the effects of PDE4 and PDE3, 2 major families expressed in hearts, 9 on PKA FRET ratio at resting state or after ␤AR activation. At resting wild-type myocytes, inhibition of PDE4 with rolipram, but not inhibition of PDE3 with cilostamide or vehicle alone, increased baseline levels of FRET ratio (Figure 2A , 2B, and 2E, respectively), suggesting that PDE4 plays a key role in controlling baseline PKA activities. Surprisingly, inhibition of all PDE activity with IBMX promoted much higher increases in FRET ratio than those with rolipram ( Figure 2C and 2F), indicating potential involvement of other non-PDE4 families in maintaining baseline PKA activities. Interestingly, rolipram and cilostamide together promoted higher increases in FRET ratio than rolipram alone, although the levels were still significantly lower than those induced by IBMX ( Figure 2D and 2F), indicating a synergistic effect between PDE3 and PDE4, 17 and supporting involvement of additional PDE families in maintaining baseline PKA activities in myocytes.
We then examined the effects of rolipram and cilostamide on AKAR FRET increases induced by ␤AR in wild-type myocytes. At both saturating concentration (10 mol/L) and nonsaturating physiological concentration (1 nmol/L), isoproterenol induced similar initial increases in FRET ratio ( Figure 3A and 3B). However, the FRET increases induced by 1 nmol/L isoproterenol underwent rapid attenuation, whereas those induced by 10 mol/L isoproterenol remained high ( Figure 3A and supplemental Figure II ). Pretreatment with either rolipram or cilostamide blocked attenuation of FRET ratio induced by 10 mol/L isoproterenol; however, rolipram was more effective in maintaining the FRET ratio increases induced by 1 nmol/L isoproterenol than cilostamide ( Figure 3B and supplemental Figure II ). These data confirm that PDE4 are the major PDEs involved in maintaining sustained PKA activities on ␤AR agonist stimulation. 
␤ 2 AR Induces Significant but Transient PKA Activities in Cardiac Myocytes
In cardiac myocytes, cAMP accumulation induced by ␤ 2 ARs seems to be localized and restricted, and its access to PKA has produced seemingly conflicting observations on PKA-dependent substrate phosphorylation and contraction responses. 7,10 -12 Therefore, it is of great interest to detect PKA activities induced by ␤ 2 ARs in living myocytes. We took advantage of myocytes isolated from mice lacking either ␤ 1 AR or ␤ 2 AR gene, which have been very useful models to analyze ␤AR subtype-specific signaling without complication of simultaneous activation of both subtypes. 11 Stimulation of ␤ 2 ARs in ␤ 1 AR knockout (KO) myocytes with isoproterenol (10 mol/L) induced strong initial increases in FRET ratio with both magnitude (0.25Ϯ0.02) and t 1/2 (7.38Ϯ2.0 seconds; nϭ24) similar to those in wild-type cells. However, the increased FRET ratio underwent a rapid decrease to baseline levels (t 1/2 ϭ320Ϯ12 seconds, Figure 3C and supplemental Figure II) . Stimulation of ␤ 1 ARs in ␤ 2 AR-KO myocytes induced sustained increases in FRET ratio (t 1/2 , 8.76Ϯ1.3 seconds and initial response, 0.26Ϯ0.03; nϭ13) similar to those in wild-type cells ( Figure 3E and supplemental Figure II) . However, isoproterenol (10 mol/L) induced comparable increases in cAMP accumulation in ␤ 1 AR-KO and ␤ 2 AR-KO myocytes (supplemental Figure III) . Therefore, it is unlikely that sustained PKA activities under ␤ 1 AR activation are attributable to saturated cAMP accumulation. In contrast, isoproterenol (1 nmol/L) induced transient increases in FRET ratio in both ␤ 1 AR-KO (t 1/2 ϭ6.78Ϯ1.77 seconds and initial response, 0.08Ϯ0.03; nϭ96; Figure 3D and supplemental Figure II) and ␤ 2 AR-KO myocytes (t 1/2 ϭ13.26Ϯ2.91 seconds and initial response, 0.25Ϯ0.01; nϭ17; Figure 3F and supplemental Figure II) . To determine whether the difference between AKAR FRET responses induced by ␤AR subtypes is attributable to the lower expression levels of ␤ 2 AR in cardiac myocytes, we overexpressed mouse ␤ 2 AR in ␤ 1 AR-KO myocytes (supplemental Figure IV) . The extra receptors failed to promote sustained FRET responses induced by either 1 nmol/L or 10 mol/L isoproterenol, although they enhanced magnitude of FRET responses induced by 1 nmol/L isoproterenol (supplemental Figure IV) . Therefore, activation of ␤ 2 AR induces transient PKA activities, and the lower receptor expression levels may contribute, in part, to lower PKA activities when stimulated with 1 nmol/L isoproterenol in myocytes.
We further investigated whether PDE activities play a role in shaping PKA activity induced by ␤AR subtypes. At resting state, rolipram induced small increases in baseline AKAR FRET ratio in ␤ 2 AR-KO, but not ␤ 1 AR-KO myocytes, whereas cilostamide did not affect in either cell type (supplemental Figure V) . In ␤ 1 AR-KO myocytes, rolipram significantly enhanced magnitude and duration of increases in FRET ratio induced by both 10 mol/L ( Figure 3C and supplemental Figure II ) and 1 nmol/L ( Figure 3D and supplemental Figure II) isoproterenol. Cilostamide moderately enhanced only duration of increases in FRET ratio induced by 10 mol/L isoproterenol ( Figure 3C and supplemental Figure II) . In ␤ 2 AR-KO myocytes, both rolipram and cilostamide significantly enhanced magnitude and duration of FRET responses induced by 10 mol/L isoproterenol ( Figure  3E and supplemental Figure II) . However, rolipram was more effective in maintaining the FRET ratio increases induced by 1 nmol/L isoproterenol than cilostamide ( Figure 3F and supplemental Figure II) . Together, these data indicate that PDE4 are the major PDEs involved in shaping both magnitude and duration of PKA activities on stimulation of ␤AR subtypes in cardiac myocytes.
Sustained PKA Activities Induced by ␤AR Subtypes Promotes PKA Phosphorylation of Phospholamban on Sarcoplasmic Reticulum and Contraction Responses
We hypothesize that transient PKA activities induced by ␤ 2 ARs are sufficient to phosphorylate the agonist-occupied receptors but have limited access to phospholamban at distance. Isoproterenol (10 mol/L) induced significant increases of PKA phosphorylation of serine 345 and 346 on ␤ 2 ARs overexpressed in ␤ 1 AR-KO myocytes, which peaked at 3 minutes ( Figure 4A and supplemental Figure VI) . Rolipram significantly enhanced the maximal increases in PKA phosphorylation induced by isoproterenol ( Figure 4A ). In contrast, isoproterenol had minimal increase in the levels of PKA phosphorylation of phospholamban in ␤ 1 AR-KO myocytes ( Figure 4B and supplemental Figure VI, B) , which was significantly promoted by rolipram ( Figure 4B and supplemental Figure VI) . Moreover, isoproterenol also induced significant increases in PKA phosphorylation of AKAR2.2 expressed in ␤ 1 AR-KO myocytes (supplemental Figure VI) . In addition, isoproterenol induced significant increases in PKA phosphorylation of phospholamban in both wild-type and ␤ 2 AR-KO myocytes, which were not further enhanced by rolipram ( Figure 4C and 4D) . In ␤ 1 ␤ 2 AR-KO myocytes, isoproterenol failed to induce increase in levels of PKA phosphorylation of phospholamban ( Figure 4E ). Together, these data indicate that PKA activities induced by ␤ 2 AR activa- tion are primarily restricted to plasma membrane domains. These activities are accessible to the activated ␤ 2 ARs, as well as AKAR2.2 within the proximity of signaling domains. Inhibition of PDE4 promotes sustained PKA activities for phosphorylation of phospholamban on sarcoplasmic reticulum.
We further examined the role of sustained PKA activities in ␤AR-induced myocyte contraction responses. We found that overexpressing AKAR2.2 did not affect the ␤ 2 AR-induced contraction rate responses in myocytes (supplemental Figure  VII) , indicating a minimal perturbation on the ␤AR signaling, and supporting the utility of AKAR2.2 FRET responses as indicators for physiological PKA activities in myocytes. In ␤ 1 AR-KO myocytes, stimulation of ␤ 2 AR induced small increases in contraction rate, which was followed by a rapid decrease to baseline levels ( Figure 5A ). An additional of forskolin promoted further increases in contraction rate ( Figure  5A ). Rolipram did not change baseline rates, but significantly enhanced maximal increases induced by isoproterenol ( Figure  5B and 5C). In contrast, in ␤ 2 AR-KO myocytes, stimulation of ␤ 1 AR induced sustained increases in contraction rate ( Figure  5D ). Rolipram promoted small increases at baseline but did not further enhance maximal increases induced by isoproterenol ( Figure 5E and 5F).
Because activated ␤ 2 AR can couple to Gi protein in cardiac myocytes, we also examined the effect of Gi inhibitor pertussis toxin (PTX) on ␤ 2 AR-induced AKAR FRET responses in ␤ 1 AR-KO myocytes. Pretreatment with PTX did not change the initial increases in AKAR FRET ratio induced by isoproterenol but significantly attenuated the FRET decrease ( Figure 6A ). Moreover, pretreatment with either PTX or rolipram was sufficient to enhance the levels of ␤ 2 AR-dependent PKA phosphorylation of phospholamban ( Figure 6B and 6C). Pretreatment with both drugs together promoted slightly higher levels of PKA phosphorylation of phospholamban than those with either drug alone, but the difference was not significant ( Figure 6C ).
Sustained PKA Activities Are Necessary for Maintaining Increases in Myocyte Contraction Responses
The effects of rolipram on PKA activities and PKA phosphorylation of phospholamban induced by ␤ 2 ARs raised an intriguing question: whether sustained PKA activities are necessary for propagation of signal to sarcoplasmic reticulum for substrate phosphorylation. Because addition of alprenolol can rapidly attenuate increases in FRET ratio induced by isoproterenol in wild-type myocytes, we examined effect of alprenolol on isoproterenol-induced PKA phosphorylation of phospholamban by addition of antagonist after stimulation. Stimulation of ␤ARs induced time-dependent increases in PKA phosphorylation of phospholamban in wild-type myocytes that peaked at 10 minutes ( Figure 7A) . However, addition of alprenolol after isoproterenol stimulation significantly attenuated the increases in PKA phosphorylation of phospholamban ( Figure 7A ). Meanwhile, isoproterenol induced sustained increases in myocyte contraction rate; addition of alprenolol rapidly attenuated the increases to baseline ( Figure 7B and 7D) . Similarly, addition of PKA inhibitor H-89 after isoproterenol stimulation also rapidly attenuated the increases in myocyte contraction rate to baseline ( Figure 7B and  7D) . In contrast, rolipram induced small increases in contraction rate at baseline but did not further enhance the maximal increases induced by isoproterenol ( Figure 7C and 7D) . 
␤AR Subtypes Induces Distinct PKA Activities in Adult Cardiac Myocytes
To examine whether the observed PKA activities induced by ␤AR subtypes are preserved during different developmental stages, adult cardiac myocytes were isolated for FRET studies. Stimulation with 10 mol/L isoproterenol induced sustained increases in FRET ratio ( Figure 8A and 8C) and significant increases in shortening in adult wild-type and ␤ 2 AR-KO myocytes (supplemental Figure VIII) . Rolipram did not further enhance FRET responses in both cell types ( Figure 8A and 8C) . In contrast, stimulation with 10 mol/L isoproterenol induced small and transient increases in FRET ratio ( Figure 8E ) but minimal increase in myocyte shortening in ␤ 1 AR-KO myocytes (supplemental Figure VIII) ; the transient FRET responses were enhanced and prolonged by rolipram ( Figure 8E ). In comparison, stimulation with 1 nmol/L isoproterenol induced transient increases in FRET ratio in wild-type and ␤ 2 AR-KO ( Figure 8B and 8D) but not in ␤ 1 AR-KO myocytes ( Figure 8F ) and failed to enhance myocyte shortening in all 3 cell types (supplemental Figure VIII) . The transient increases in FRET ratio were prolonged by rolipram ( Figure 8B and 8D) . Together, these data indicated the PKA activities induced by ␤AR subtypes in adult myocytes are similar to those in neonatal myocytes, with smaller PKA activities under ␤ 2 AR activation in adult myocytes.
Discussion
Sustained PKA Activities Induced by ␤AR Activation in Cardiac Myocytes
The central finding in this study is that activation of ␤ARs in both wild-type and ␤ 2 AR-KO cardiac myocytes induces sustained PKA activities, drawing strong contrast to reported transient cAMP activities that peak at 1 to 2 minutes and rapidly decrease within 3 to 5 minutes in these cells. 11, 18 More importantly, the sustained PKA activities are necessary for signal propagation from cell surface to sarcoplasmic reticulum for phosphorylation of substrates such as phospholamban and for myocyte contraction responses. This observation resolves a long-standing puzzle that cAMP accumulation induced by ␤AR activation does not show a linear correlation with receptorinduced myocyte contraction responses. 15 It also poses signifi- cant implications on a broad range of physiological processes under neurohormonal stimulation. It is generally assumed that magnitudes of signaling are a major determining factor on intensities of physiological responses. However, sustained PKA activities certainly offer advantages for signaling propagation in many physiological processes than supercharged PKA activities. First, it prevents hyperphosphorylation in substrates and related dysfunction. Second, it promotes a gradual build up of signal cross a whole cell during stresses. Third, sustained PKA activities are dependent on continuous stimulation, which is correlated with sustained catecholamine release from nerve in vivo. Withdrawing stimuli leads to a rapid decrease of PKA activities to baseline levels. Together, sustained but not supercharged PKA activities ensure a steady propagation of signal from plasma membrane to deep inside of a cell.
It is not clear how a transient cAMP activity can be converted into a sustained PKA activity. One possible scenario is that an initial surge of cAMP promotes binding to PKA. The high binding affinity to PKA reduces degradation rate of bound cAMP and contributes to slow attenuation of the PKA activity. Meanwhile, agonist isoproterenol-induced PKA activities can be rapidly reversed by addition of antagonist alprenolol or removal of isoproterenol, indicating that occupancy of ␤ARs by agonist is necessary to maintain sustained PKA activities. A continuous production of cAMP must play a role in maintaining sustained PKA activities in cardiac myocytes, which may feed the equilibrium between binding and unbinding of cAMP to PKA. In support of this notion, cAMP accumulation displays a biphasic response with an initial transient peak followed by a sustained small increase over baseline levels in both cardiac myocytes and HEK293 fibroblasts during extended ␤AR stimulation. 11, 18 Given the comparable cAMP accumulation induced by both ␤ 1 AR and ␤ 2 AR, it is unlikely that the ␤ 1 AR-induced sustained PKA activities are attributable to saturation of the FRET reporters with super-high accumulation of cAMP. Indeed, inhibition of PDE4 can further enhance the maximal FRET responses. Meanwhile, it is likely that PKA-associated phosphatase activities on ␤AR activation 15 play an essential role in shaping FRET ratio responses in our experiments, which remains to be addressed in future studies.
Transient PKA Activities Induced by ␤ 2 ARs Lead to Differential Phosphorylation of Substrates on Plasma Membrane and Sarcoplasmic Reticulum
Another interesting finding in this study is that stimulation of ␤ 2 ARs induces transient PKA activities that are sufficient to phosphorylate activated receptors on plasma membrane but not phospholamban on sarcoplasmic reticulum. It has been well documented that stimulation of ␤ 2 AR does not make significant contribution on myocardium contraction in animal hearts and isolated myocytes. 11, 12 This notion is further supported by biochemical and electrophysiological evidence that ␤ 2 AR activation has minimal effect on phosphorylation of substrates such as phospholamban 12 and has restricted effect on PKA-dependent activation of L-type calcium channels within vicinities of activated receptors. 19 On the other hand, studies show that stimulation of ␤ 2 ARs induces significant cellular cAMP in both fibroblasts and cardiac myocytes 18, 20 but with limited diffusion in adult cardiac myocytes. 7 Here, we address this long-standing question by revealing real-time PKA activities induced by ␤ 2 ARs in living myocytes. Our data show that cAMP induced by ␤ 2 ARs does have access to PKA, which yields initial maximal activities equivalent to those induced by ␤ 1 ARs under stimulation with saturated concentration of agonist. However, these increased PKA activities are transient and highly restricted and only accessible to substrates within local vicinities of activated receptors.
PDE Enzymes Control Baseline PKA Activities and Shape ␤AR-Stimulated PKA Activities
Maintenance of tonic cAMP/PKA activities acts as an essential regulatory mechanism on cellular function at resting state, in particular in excitable neurons and myocytes. However, little evidence is available, in part, because of relative insensitivity of measurements on cAMP and PKA activities. Using the PKA reporter, we find that PDE4 is one of major factors that control baseline levels of PKA activities. Inhibition of PDE4 with rolipram increases baseline PKA activities in ␤ 2 AR-KO myocytes, suggesting spontaneous ␤ 1 AR activation at resting state. In agreement, inhibition of PDE4 elevates PKA activities to increase phosphorylation of ␤ 1 ARs expressed in HEK293 fibroblasts. 9 Interestingly, inhibition of all PDE enzymes with IBMX induces much higher PKA activities at resting state than those with rolipram. This is, in part, attributable to synergistic effects between PDE4 and PDE3 in cardiac myocytes. 17 However, PKA activities induced by inhibition of PDE3 and PDE4 together are significantly lower than those induced by IBMX, which underscores involvement of other IBMX-sensitive PDE families, such as PDE2 and PDE7, 21 in complicated regulation of tonic cAMP/ PKA activities in cardiac myocytes.
On stimulation, ␤ 2 AR-induced PKA activities display a strong initial increase followed by a rapid decrease to baseline levels. Inhibition of PDE4 significantly reduces attenuation of the increased PKA activities and reshapes overall responses similar to those induced by ␤ 1 ARs. Inhibition of PDE4 also completely blocks slow attenuation of ␤ 1 AR-induced PKA activities. These observations are consistent with preferential association of PDE4D isoforms with ␤ 1 -and ␤ 2 ARs at resting and stimulating conditions. 9,22,23 PDE4 enzymes have basal activities under resting conditions, which can be enhanced by PKA phosphorylation for cAMP degradation. 4, 24, 25 PDE4D8 directly bind to ␤ 1 ARs and dissociate from the receptors on agonist stimulation, indicating constitutive basal PDE4 activities associated with ␤ 1 ARs at resting state. This is in contrast to the agonist-induced and arrestin-dependent recruitment of PDE4D3 and PDE4D5 to ␤ 2 ARs, a potential mechanism for activated PDE4 on cAMP degradation, which can be further modulated by the coupling of activated ␤ 2 ARs to Gi protein. The mechanisms on governing ␤AR subtype-induced PKA activities by PDE4 isoforms remains to be further addressed.
Together, by using real-time, FRET-based imaging of PKA activity in living myocytes, we report, for the first time, that stimulation of ␤AR subtypes induces distinct temporal profiles of activation of PKA. Activation of ␤ARs induces strong and sustained PKA activities in wild-type myocytes. The sustained PKA activities are dependent on agonist occupancy of receptors and are necessary for signaling propagation to sarcoplasmic reticulum for phosphorylation of phospholamban and for myocyte contraction responses. In contrast, activation of ␤ 2 AR induces a strong activation of PKA that undergoes a rapid decrease after reaching peak levels. The transient PKA activities are sufficient for phosphorylation of the activated receptors but not phospholamban for myocyte contraction responses. Together, our data have revealed insights into kinetics of PKA activities under neurohormonal stimulation with implication in a broad range of physiological processes.
